Independent society publishers and the path to open scholarship

Q4 Biochemistry, Genetics and Molecular Biology
Biochemist Pub Date : 2023-06-22 DOI:10.1042/bio_2023_117
Gaynor Redvers-Mutton, John Doddy
{"title":"Independent society publishers and the path to open scholarship","authors":"Gaynor Redvers-Mutton, John Doddy","doi":"10.1042/bio_2023_117","DOIUrl":null,"url":null,"abstract":"The scholarly publishing landscape is undergoing rapid change owing to global events such as the coronavirus pandemic, political statements such as the OSTP Nelson memo in the USA1 and funder moves such as Plan S in Europe2. These combined factors have triggered unprecedented moves towards open access and the broader establishment of open scholarship agendas among publishers, with a view to supporting global scientific research.As an independent society publisher navigating a path to open scholarship, here’s everything you need to know about the Biochemical Society’s future publishing vision and the steps we’re taking to safeguard our support for the molecular bioscience community.Despite a history of curating ‘science’ by creating many of the most impactful journals, independent society publishers are an increasingly rare phenomenon in scholarly publishing. As we navigate new research agendas, the Biochemical Society is choosing to stand behind an equitable and inclusive funding model to cover publishing costs, challenging the more commercial imperatives of open access publishing, which seek to commodify the process of sharing research in pursuit of greater market share.By choosing sustainable business models, we plan to remain independent so that we can continue to make choices in line with our strategy and mission, decide our own priorities and remain at a scale that enables publishing to be an important and integral part of what we bring to the research endeavour – rather than an end in itself. We trust our key communities – researchers, librarians and other stakeholders worldwide – align with these principles and will support us in our on-going journey towards more open research practices.The first choice we’ve made is to remain in control of our own destiny and follow self-determined priorities. The second is to find as many routes as possible to achieve fee-free open access publishing options for all our authors. Ensuring researchers have the chance to be published based on scientific merit has been at the heart of the Society’s publishing ethos and will continue in our open science future.The Society’s governance structure, which sees scientists guiding decisions about our sustainability, sits in contrast to more commercial shareholder interests. Our publishing surpluses are there to support scholars throughout their careers as they pursue interconnected research endeavours, providing forums for researchers to communicate and discuss their discoveries with peers, and to exercise their talents and creativity to advance their discipline.The Society plans to scale up open scholarship ambitions over the next two years. Many of the publishing services we offer authors and customers are ‘bundled in’ to increasingly outdated licence agreements. In future, we will work with our communities to identify and deliver more services and better define service levels so that they may be formalized in new agreements.Increasingly, we will move away from generating publishing income by licensing access to content. Measuring usage as we do currently will need rethinking as gated access points become redundant; however, we do expect to continue to provide evidenced measures of usage to our customers and to provide a high-quality reading experience and full suite of reader-based services. Industries, government bodies and commercial interests who rely on published research (though may not fund the publishing side of it) will be forefront in defining requirements for paid-for services, which enable them to consume and manage scientific outputs.Moving towards a fully open access future, where every author has a fee-free and compliant route, will offer more choices for both authors and their institutions and funders. Maintaining the tradition of fully inclusive, wholly equitable access to our publishing venues, our ambition is to publish top-tier journals of choice for all molecular bioscientists. Alongside our partner societies, we offer our authors the following reasons for choosing to publish in a society journal:While recent events have triggered the urgency of open access in scientific research, determined but piecemeal open access initiatives over the past two decades had already laid the groundwork for such change, and we are not alone in forming scaled-up transition plans in response.There are three key influences on why transition to full open access has had such acute scrutiny at the Biochemical Society:Authors benefit from their work being open access. It is easier for them to share the results of their work with colleagues and peers and it is easier for us to market and promote. We have started to analyse our own datasets and the results show a 1.5-fold citation advantage and 4.5-fold increase in usage of open access over paywalled articles3.The Biochemical Society publishes seven journals via our publishing arm, Portland Press. All profits earned through this business model are gifted straight back to the Society and this funds a range of activities that give back to and support the molecular bioscience community, in turn helping to advance the careers of researchers across the bioscience sector. Through careful management of budgets and reserves, we expect to maintain our level of activity and initiate more funded projects, products and services in the delivery of our core mission.Biochemical Society Journals: a home for every paper across the molecular biosciencesWe are excited about the changes ahead. By adapting and taking a forward-thinking approach to the mechanisms of sharing research and knowledge, we aim to hold fast to principles that remain as relevant today, in an open access world, as they did when the Society was first formed over 100 years ago. We will continue to promote research without sacrificing quality and integrity, remaining a trusted player putting all surpluses back into our community for the advancement of molecular bioscience.The landscape ahead will undoubtedly bring many changes and we look forward to working alongside the varied stakeholders within our community to support our mutual interests for the benefit of wider society. In the meantime, visit our open scholarship page for more on our work in this area and stay tuned for further developments as we take steps towards a more open scientific output.","PeriodicalId":35334,"journal":{"name":"Biochemist","volume":"45 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1042/bio_2023_117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

The scholarly publishing landscape is undergoing rapid change owing to global events such as the coronavirus pandemic, political statements such as the OSTP Nelson memo in the USA1 and funder moves such as Plan S in Europe2. These combined factors have triggered unprecedented moves towards open access and the broader establishment of open scholarship agendas among publishers, with a view to supporting global scientific research.As an independent society publisher navigating a path to open scholarship, here’s everything you need to know about the Biochemical Society’s future publishing vision and the steps we’re taking to safeguard our support for the molecular bioscience community.Despite a history of curating ‘science’ by creating many of the most impactful journals, independent society publishers are an increasingly rare phenomenon in scholarly publishing. As we navigate new research agendas, the Biochemical Society is choosing to stand behind an equitable and inclusive funding model to cover publishing costs, challenging the more commercial imperatives of open access publishing, which seek to commodify the process of sharing research in pursuit of greater market share.By choosing sustainable business models, we plan to remain independent so that we can continue to make choices in line with our strategy and mission, decide our own priorities and remain at a scale that enables publishing to be an important and integral part of what we bring to the research endeavour – rather than an end in itself. We trust our key communities – researchers, librarians and other stakeholders worldwide – align with these principles and will support us in our on-going journey towards more open research practices.The first choice we’ve made is to remain in control of our own destiny and follow self-determined priorities. The second is to find as many routes as possible to achieve fee-free open access publishing options for all our authors. Ensuring researchers have the chance to be published based on scientific merit has been at the heart of the Society’s publishing ethos and will continue in our open science future.The Society’s governance structure, which sees scientists guiding decisions about our sustainability, sits in contrast to more commercial shareholder interests. Our publishing surpluses are there to support scholars throughout their careers as they pursue interconnected research endeavours, providing forums for researchers to communicate and discuss their discoveries with peers, and to exercise their talents and creativity to advance their discipline.The Society plans to scale up open scholarship ambitions over the next two years. Many of the publishing services we offer authors and customers are ‘bundled in’ to increasingly outdated licence agreements. In future, we will work with our communities to identify and deliver more services and better define service levels so that they may be formalized in new agreements.Increasingly, we will move away from generating publishing income by licensing access to content. Measuring usage as we do currently will need rethinking as gated access points become redundant; however, we do expect to continue to provide evidenced measures of usage to our customers and to provide a high-quality reading experience and full suite of reader-based services. Industries, government bodies and commercial interests who rely on published research (though may not fund the publishing side of it) will be forefront in defining requirements for paid-for services, which enable them to consume and manage scientific outputs.Moving towards a fully open access future, where every author has a fee-free and compliant route, will offer more choices for both authors and their institutions and funders. Maintaining the tradition of fully inclusive, wholly equitable access to our publishing venues, our ambition is to publish top-tier journals of choice for all molecular bioscientists. Alongside our partner societies, we offer our authors the following reasons for choosing to publish in a society journal:While recent events have triggered the urgency of open access in scientific research, determined but piecemeal open access initiatives over the past two decades had already laid the groundwork for such change, and we are not alone in forming scaled-up transition plans in response.There are three key influences on why transition to full open access has had such acute scrutiny at the Biochemical Society:Authors benefit from their work being open access. It is easier for them to share the results of their work with colleagues and peers and it is easier for us to market and promote. We have started to analyse our own datasets and the results show a 1.5-fold citation advantage and 4.5-fold increase in usage of open access over paywalled articles3.The Biochemical Society publishes seven journals via our publishing arm, Portland Press. All profits earned through this business model are gifted straight back to the Society and this funds a range of activities that give back to and support the molecular bioscience community, in turn helping to advance the careers of researchers across the bioscience sector. Through careful management of budgets and reserves, we expect to maintain our level of activity and initiate more funded projects, products and services in the delivery of our core mission.Biochemical Society Journals: a home for every paper across the molecular biosciencesWe are excited about the changes ahead. By adapting and taking a forward-thinking approach to the mechanisms of sharing research and knowledge, we aim to hold fast to principles that remain as relevant today, in an open access world, as they did when the Society was first formed over 100 years ago. We will continue to promote research without sacrificing quality and integrity, remaining a trusted player putting all surpluses back into our community for the advancement of molecular bioscience.The landscape ahead will undoubtedly bring many changes and we look forward to working alongside the varied stakeholders within our community to support our mutual interests for the benefit of wider society. In the meantime, visit our open scholarship page for more on our work in this area and stay tuned for further developments as we take steps towards a more open scientific output.
独立社会出版商和开放学术的道路
由于冠状病毒大流行等全球性事件、美国OSTP纳尔逊备忘录等政治声明以及欧洲S计划等资助者举措,学术出版格局正在发生迅速变化。这些综合因素引发了前所未有的开放获取行动,并在出版商之间更广泛地建立开放奖学金议程,以支持全球科学研究。作为一个独立的学会出版商,在通往开放学术的道路上,这里是你需要知道的关于生化学会未来出版愿景的一切,以及我们为保障我们对分子生物科学界的支持所采取的步骤。尽管通过创建许多最具影响力的期刊来策划“科学”的历史,但独立的学会出版商在学术出版领域越来越罕见。当我们引导新的研究议程时,生化学会选择支持一个公平和包容的资助模式来支付出版成本,挑战开放获取出版的更多商业必要性,后者试图将共享研究的过程商品化,以追求更大的市场份额。通过选择可持续的商业模式,我们计划保持独立,这样我们就可以继续根据我们的战略和使命做出选择,决定我们自己的优先事项,并保持一定的规模,使出版成为我们为研究工作带来的重要而不可或缺的一部分,而不是最终目的。我们相信我们的关键社区——研究人员、图书馆员和世界各地的其他利益相关者——与这些原则保持一致,并将支持我们朝着更开放的研究实践的持续旅程。我们所做的第一个选择是继续掌握自己的命运,遵循自己决定的优先事项。第二是尽可能多地为我们所有的作者提供免费的开放获取出版选择。确保研究人员有机会基于科学价值发表论文一直是该协会出版精神的核心,并将在我们开放科学的未来继续下去。该协会的治理结构与更多的商业股东利益形成鲜明对比,在这种结构中,科学家指导有关可持续发展的决策。我们的出版盈余是为了支持学者们的整个职业生涯,因为他们追求相互关联的研究努力,为研究人员提供论坛,与同行交流和讨论他们的发现,并锻炼他们的才能和创造力,以推进他们的学科。该协会计划在未来两年内扩大开放奖学金的规模。我们为作者和客户提供的许多出版服务都与日益过时的许可协议捆绑在一起。未来,我们将与社区合作,确定和提供更多的服务,更好地定义服务水平,以便在新的协议中正式确定服务水平。我们将逐渐摆脱通过授权内容获取出版收入的模式。随着门禁接入点变得多余,我们目前衡量使用率的方式需要重新思考;然而,我们确实希望继续为我们的客户提供有效的使用方法,并提供高质量的阅读体验和全套基于读者的服务。依赖已发表研究的工业、政府机构和商业利益集团(尽管可能不资助其出版方面)将在确定付费服务需求方面走在前列,这些服务使他们能够消费和管理科学成果。走向完全开放获取的未来,每位作者都有免费和合规的途径,将为作者及其机构和资助者提供更多选择。我们的目标是保持完全包容、完全公平地进入我们的出版场所的传统,为所有分子生物科学家出版首选的顶级期刊。与我们的合作协会一起,我们为我们的作者提供了以下选择在学会期刊上发表文章的理由:虽然最近的事件引发了科学研究开放获取的紧迫性,但过去二十年中坚定但零碎的开放获取倡议已经为这种变化奠定了基础,我们并不是唯一形成大规模过渡计划的人。为什么向完全开放获取的过渡在生化学会受到如此严格的审查,有三个关键的影响:作者从他们的工作开放获取中受益。他们更容易与同事和同行分享他们的工作成果,我们也更容易进行营销和推广。我们已经开始分析我们自己的数据集,结果显示,与付费墙文章相比,开放获取的引用优势为1.5倍,使用优势为4.5倍。生化学会通过我们的出版机构波特兰出版社出版了7种期刊。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biochemist
Biochemist Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
1.20
自引率
0.00%
发文量
41
期刊介绍: This lively and eclectic magazine for all life scientists appears six times a year. Its quirky style and astute selection of serious and humorous articles ensures that the magazine"s appeal is by no means restricted to that of the avid biochemist. Specially commissioned articles from leading scientists bring a popular science perspective direct to you! Forthcoming themes include: RNAi, Money in Science, Extremophiles, Biosystems and Mathematical Modelling, Renascence of Mitochondria, Prions & Protein factors, Imaging live cells and Model organisms.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信